Back to search
FDAFDA · Food and drugs·Recall number D-0749-2022

Sucralfate Oral Suspension, USP 1g/10mL, packaged in a) 40 case of 10 mL unit Dose Cups (NDC 69339-148-17) and b) 100 case of 10 mL Unit Dose Cups (NDC 69339-148-19) Rx Only, Dash Pharmaceuticals, Upper Saddle River, NJ 07458.

Published April 13, 2022 · Recall initiated: March 11, 2022

Summary

FDA records drug Class II recall D-0749-2022, published April 13, 2022 and initiated March 11, 2022. Recalling firm: DASH Pharmaceuticals LLC; Status: Terminated; Reported quantity: 45,940 Unit Dose Cups; Lot: Lot #: a) 376908P40, Exp. Date 02/28/2023; b) 376908P100, Exp. Date 02/28/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Mix-Up

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
DASH Pharmaceuticals LLC
Distributor
Nationwide within the United States
Lot
Lot #: a) 376908P40, Exp. Date 02/28/2023; b) 376908P100, Exp. Date 02/28/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sucralfate Oral Suspension, USP 1g/10mL, packaged in a) 40 case of 10 mL unit Dose Cups (NDC 69339-148-17) and b) 100 case of 10 mL Unit Dose Cups (NDC 69339-148-19) Rx Only, Dash Pharmaceuticals, Upper Saddle River, NJ 07458. recalled?

Yes. FDA published recall D-0749-2022 on April 13, 2022. Reported hazard: Labeling: Label Mix-Up

What should I do if I have this product?

Voluntary: Firm initiated · Letter